Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06961305Not ApplicableCompleted

A Post-Marketing Study of Alexa Medium for Сorrection of the Lips Volume Loss

Role: lead

NCT06984419Not ApplicableCompleted

Clinical Investigation of the Medical Device "Alexa Volume" for Correction of Midface Volume Loss

Role: lead

NCT06984432Not ApplicableCompleted

Evaluation of a Non-cross-linked Hyaluronic Acid Medical Device ("Electri" and "XELA REDERM") for Improving Facial Skin Appearance

Role: lead

All 3 trials loaded